Evidence map›Paper›PMID 35784010›Full record

ArticleAmerican heart journal plus : cardiology research and practice2022

Ultra-high sensitivity cardiac troponin-I concentration and left ventricular structure and function in women with ischemia and no obstructive coronary artery disease.

Odayme Quesada, Omeed Elboudwarej, Michael D Nelson, Ahmed Al-Badri, Mitra Mastali, Janet Wei, Bijan Zarrabi, Nissi Suppogu, Haider Aldiwani, Puja Mehta and 8 more

Open access · goldAbstract read
In one paragraph

Article in American heart journal plus : cardiology research and practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. High-sensitivity cardiac troponin I and frailty: associations with the frailty index and Fried phenotype in older women.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Article
  2. Myocardial biomarkers in coronary microvascular dysfunction: Response to ranolazine.American heart journal plus : cardiology research and practice · 2025
    Article
  3. Article
  4. Review
  5. ANOCA/INOCA/MINOCA: Open artery ischemia.American heart journal plus : cardiology research and practice · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 1 country.

Odayme QuesadaBarbra Streisand Women's Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.
Omeed ElboudwarejBarbra Streisand Women's Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.
Michael D NelsonApplied Physiology and Advanced Imaging Laboratory, University of Texas at Arlington, Arlington, TX, United States of America.
Ahmed Al-BadriBarbra Streisand Women's Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.
Mitra MastaliAdvanced Clinical BioSystems Research Institute Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.
Janet WeiBarbra Streisand Women's Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.
Bijan ZarrabiBarbra Streisand Women's Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.
Nissi SuppoguBarbra Streisand Women's Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.
Haider AldiwaniBarbra Streisand Women's Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.
Puja MehtaEmory Women's Heart Center, Emory University School of Medicine, Atlanta, GA, United States of America.
Chrisandra ShufeltBarbra Streisand Women's Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.
Galen Cook-WiensBiostatistics and Bioinformatics Research Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.
Daniel S BermanMark S. Taper Imaging Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.
Louise E J ThomsonMark S. Taper Imaging Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.
Eileen HandbergDivision of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL 32610-0277, United States of America.
Carl J PepineDivision of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL 32610-0277, United States of America.
Jennifer E Van EykAdvanced Clinical BioSystems Research Institute Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.
C Noel Bairey MerzBarbra Streisand Women's Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.
Cedars-Sinai Medical Center · USCedars-Sinai Smidt Heart Institute · USUniversity of Florida · USEmory University · USImaging Center · USThe University of Texas at Arlington · US

Funding

The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE)U54AG065141 · NIA · CEDARS-SINAI MEDICAL CENTER · PI BAIREY MERZ, CATHLEEN NOEL, CHENG, SUSAN · 2020 to 2024
$8.7M
Women's Ischemia Syndrome Evaluation (WISE) - Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF)R01HL146158 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI BAIREY MERZ, CATHLEEN NOEL · 2019 to 2023
$3.7M
Hypertensive Disorders of Pregnancy: Pathways to Future Cardiovascular DiseaseK23HL151867 · NHLBI · THE CHRIST HOSPITAL · PI QUESADA, ODAYME · 2020 to 2024
$799k
NHLBI NIH HHS K23 HL151867NHLBI NIH HHS R01 HL146158NIA NIH HHS U54 AG065141
6 · The paper itself

Abstract

Aims: Women are disproportionally impacted by ischemia and no obstructive coronary artery disease (INOCA), and such women are at increased risk of developing heart failure with preserved ejection fraction (HFpEF), however the mechanisms linking these conditions remain poorly understood. The aim of this study was to determine whether ultra-high sensitivity cardiac troponin I (u-hscTnI), an indicator of cardiomyocyte injury, is associated with abnormalities in myocardial perfusion and left ventricular (LV) structure and function in women with INOCA. Methods: 327 women with INOCA enrolled in the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study underwent vasodilator stress cardiac magnetic resonance imaging (CMRI) and u-hscTnI measurements (Simoa HD-1 Analyzer, Quanterix Corporation). Multivariable linear regression was used to evaluate associations between u-hscTnI concentrations and myocardial perfusion (MPRI), LV mass index and feature-tracking derived strain measures of LV function. Results: u-hscTnI concentrations were quantifiable in 100% of the cohort and ranged from 0.004 to 79.6 pg/mL. In adjusted models, u-hscTnI was associated with LV mass index (+2.03; 95% CI 1.17, 2.89; Conclusion: Together, these findings support cardiomyocyte injury as a putative pathway towards adverse LV remodeling and dysfunction; however, further research is needed to define the specific mechanism(s) driving myocellular injury in INOCA.

Indexed as

Cardiomyocyte injuryDiastolic strainIschemia and no obstructive coronary artery disease (INOCA)Left ventricular dysfunctionLeft ventricular massUltra-high sensitivity cardiac troponin

Identifiers

PMID35784010
PMCPMC9246284
OpenAlexW4214901905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.